This inventor holds 17 USPTO granted patents, plus 1 CIPO patent, primarily in Proteasome Inhibitors. Top assignees: Cephalon, Inc., Cephalon France, Millennium Pharmaceuticals Limited. Active years: 1996-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
16 out of 248 
3 out of 20 
1 out of 855 
Years Active: 1996-2016
Areas of Expertise:
Title: **Inventor Spotlight: Mohamed A. Iqbal**
Introduction
Mohamed A. Iqbal, an accomplished inventor based in Malvern, PA, has made significant strides in the field of biochemistry. With a total of 17 patents to his name, his work primarily focuses on innovative treatments for diseases, particularly cancer. His contributions have been critical in developing new methods that harness the power of proteasome inhibitors.
Latest Patents
Among his notable recent patents is one that centers on "Proteasome inhibitors and methods of using the same." This invention presents a variety of boronic acid compounds and boronic esters, which are capable of modulating apoptosis by inhibiting proteasome activity. These compounds and their compositions are designed for use in methodologies that induce apoptosis and treat diseases, including cancer and other disorders directly or indirectly linked to proteasome function. His innovative approach aims to provide novel treatment options for challenging medical conditions.
Career Highlights
Throughout his career, Mohamed A. Iqbal has gained valuable experience working with prominent organizations such as Cephalon, Inc. and its French subsidiary, Cephalon France. His tenure in these companies has provided him with a robust foundation for his research and development in pharmacological innovations.
Collaborations
Iqbal has collaborated with notable colleagues, including Sankar Chatterjee and James C. Kauer, contributing to various research initiatives and enhancing the breadth of his innovative efforts. These partnerships have enabled him to push the boundaries of current knowledge and practices in his field.
Conclusion
In summary, Mohamed A. Iqbal stands out as a leading inventor in the biotech industry, with a rich portfolio of patents that reflect his dedication to advancing medical science. His ongoing work with proteasome inhibitors showcases his commitment to developing effective treatments for serious ailments, particularly cancer. With the potential for his inventions to make significant impacts in healthcare, Iqbal's innovations are an essential part of the future of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile